Finch Therapeutics' Series B Round

Finch Therapeutics raised a round of funding on March 01, 2018.

Finch Therapeutics, formerly NextBiome, feeds clinical studies of microbial interventions into its integrated machine-learning platform to identify the specific microbial agents that drive clinical re…

Articles about Finch Therapeutics' Series B Round: